The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials.
- DOI
- 10.1016/j.critrevonc.2022.103674
- Published
- 2022 May
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2022.103674,
title = {The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials.},
author = {Dubois M and Liscia N and Brunetti O and Ziranu P and Lai E and Argentiero A and Mazza E and Cascinu S and Silvestris N and Casadei-Gardini A and Scartozzi M},
year = {2022},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2022.103674},
url = {https://doi.org/10.1016/j.critrevonc.2022.103674}
}RIS
TY - JOUR TI - The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials. AU - Dubois M AU - Liscia N AU - Brunetti O AU - Ziranu P AU - Lai E AU - Argentiero A AU - Mazza E AU - Cascinu S AU - Silvestris N AU - Casadei-Gardini A AU - Scartozzi M PY - 2022 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2022.103674 UR - https://doi.org/10.1016/j.critrevonc.2022.103674 ER -
APA
M, D., N, L., O, B., P, Z., E, L., A, A., E, M., S, C., N, S., A, C., & M, S. (2022). The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2022.103674
Source records
- pubmed · retrieved 2026-09-25T18:33:01.360Z
- europe-pmc · retrieved 2026-09-25T18:33:01.348Z